Perfect Medical Health Management Limited
Символ: 1830.HK
HKSE
3.12
HKDПазарна цена днес
9.3272
Съотношение P/E
0.0000
Коефициент PEG
3.92B
MRK Cap
- 0.02%
Доходност на DIV
Perfect Medical Health Management Limited (1830-HK) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2377.3 | 656.8 | 454.4 | 532.9 | |||||||||||||
balance-sheet.row.short-term-investments | 270.64 | 210.2 | 0.2 | 34.3 | |||||||||||||
balance-sheet.row.net-receivables | 195.92 | 50.3 | 16 | 79.5 | |||||||||||||
balance-sheet.row.inventory | 30.95 | 8.9 | 5.9 | 2.8 | |||||||||||||
balance-sheet.row.other-current-assets | 161.56 | 36.2 | 31.9 | 38.6 | |||||||||||||
balance-sheet.row.total-current-assets | 2765.72 | 752.3 | 508.1 | 653.8 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 1764.45 | 409.9 | 553.3 | 435.6 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-investments | 360.1 | 89 | 110.4 | 309.1 | |||||||||||||
balance-sheet.row.tax-assets | 128.15 | 8.5 | 56.5 | 53.9 | |||||||||||||
balance-sheet.row.other-non-current-assets | 176.91 | 36.6 | 52.9 | 28 | |||||||||||||
balance-sheet.row.total-non-current-assets | 2429.61 | 544 | 773.1 | 826.6 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 5195.33 | 1296.3 | 1281.2 | 1480.4 | |||||||||||||
balance-sheet.row.account-payables | 5.4 | 0.8 | 1.6 | 0.7 | |||||||||||||
balance-sheet.row.short-term-debt | 466.96 | 114.5 | 135.4 | 105.6 | |||||||||||||
balance-sheet.row.tax-payables | 376.86 | 85.6 | 89.7 | 45.5 | |||||||||||||
balance-sheet.row.long-term-debt-total | 539.22 | 125.9 | 175.7 | 156 | |||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 184.5 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 636.81 | 153.4 | 149.3 | 136.4 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 786.45 | 163.2 | 264 | 236 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 539.22 | 125.9 | 175.7 | 156 | |||||||||||||
balance-sheet.row.total-liab | 2944.51 | 684 | 786.9 | 795.5 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 501.07 | 125.7 | 124 | 122.3 | |||||||||||||
balance-sheet.row.retained-earnings | 717.87 | 200.2 | 91.6 | 259.8 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -252.25 | -50 | -50.5 | -30.5 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1284.14 | 336.5 | 329.2 | 333.3 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 2250.83 | 612.3 | 494.3 | 684.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5195.33 | 1296.3 | 1281.2 | 1480.4 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-equity | 2250.83 | 612.3 | 494.3 | 684.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5195.33 | - | - | - | |||||||||||||
Total Investments | 630.75 | 299.2 | 110.6 | 343.4 | |||||||||||||
balance-sheet.row.total-debt | 1006.19 | 240.4 | 311.1 | 261.6 | |||||||||||||
balance-sheet.row.net-debt | -1100.46 | -206.3 | -143.1 | -237 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 570.86 | 315.6 | 305.2 | 284.6 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 442.94 | 223.6 | 219 | 171.3 | |||||||||||||
cash-flows.row.deferred-income-tax | -293.47 | -460.8 | -416.8 | -343 | |||||||||||||
cash-flows.row.stock-based-compensation | 4.24 | 4.2 | 4.6 | 3.1 | |||||||||||||
cash-flows.row.change-in-working-capital | 34.86 | 9.7 | -73.7 | 152.1 | |||||||||||||
cash-flows.row.account-receivables | 28.22 | -23.7 | 63.2 | -3.2 | |||||||||||||
cash-flows.row.inventory | -6.1 | -3 | -3.1 | -1 | |||||||||||||
cash-flows.row.account-payables | 0 | 17.3 | -34.3 | 6.8 | |||||||||||||
cash-flows.row.other-working-capital | 12.74 | 19.1 | -99.5 | 149.5 | |||||||||||||
cash-flows.row.other-non-cash-items | 878.01 | 468.3 | 478.4 | 337.7 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1005.94 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -171.29 | -26.7 | -144.6 | -78.2 | |||||||||||||
cash-flows.row.acquisitions-net | 1.6 | 0.2 | 1.6 | 1.9 | |||||||||||||
cash-flows.row.purchases-of-investments | 0 | -210 | -233.5 | -720.6 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 16.3 | 385.4 | 496.9 | |||||||||||||
cash-flows.row.other-investing-activites | 266.63 | -2.3 | -0.9 | -0.8 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 95.49 | -222.5 | 8.1 | -300.8 | |||||||||||||
cash-flows.row.debt-repayment | -134.68 | -135.7 | -137.7 | -109.5 | |||||||||||||
cash-flows.row.common-stock-issued | 15 | 15 | 15 | 15 | |||||||||||||
cash-flows.row.common-stock-repurchased | -31.7 | -10 | -21.7 | -4.5 | |||||||||||||
cash-flows.row.dividends-paid | -597.27 | -191.8 | -405.5 | -282.3 | |||||||||||||
cash-flows.row.other-financing-activites | -349.95 | -12.5 | -16.1 | -13.1 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -1098.6 | -335 | -566 | -394.4 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -20.25 | -9.9 | -3.2 | 21 | |||||||||||||
cash-flows.row.net-change-in-cash | -23.22 | -7.5 | -44.4 | -67.9 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 2106.65 | 446.6 | 454.2 | 498.6 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2129.87 | 454.2 | 498.6 | 566.5 | |||||||||||||
cash-flows.row.operating-cash-flow | 1005.94 | 560.6 | 516.7 | 605.9 | |||||||||||||
cash-flows.row.capital-expenditure | -171.29 | -26.7 | -144.6 | -78.2 | |||||||||||||
cash-flows.row.free-cash-flow | 834.64 | 533.8 | 372.2 | 527.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2655.74 | 1389.3 | 1350 | 1089.8 | |||||||||||||
income-statement-row.row.cost-of-revenue | 1383.29 | 726.7 | 660 | 536.3 | |||||||||||||
income-statement-row.row.gross-profit | 1272.45 | 662.6 | 689.9 | 553.4 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 275.51 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 313.86 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | -0.5 | -1.5 | -0.4 | |||||||||||||
income-statement-row.row.operating-expenses | 589.37 | 293.8 | 306.1 | 250.6 | |||||||||||||
income-statement-row.row.cost-and-expenses | 1972.66 | 1020.5 | 966.2 | 786.9 | |||||||||||||
income-statement-row.row.interest-income | 16.12 | 7.9 | 1.7 | 5.4 | |||||||||||||
income-statement-row.row.interest-expense | 26.17 | 12.5 | 16.1 | 13.1 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 313.86 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 22.56 | 22.6 | -5.6 | 55.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.5 | -1.5 | -0.4 | |||||||||||||
income-statement-row.row.total-operating-expenses | 22.56 | 22.6 | -5.6 | 55.3 | |||||||||||||
income-statement-row.row.interest-expense | 26.17 | 12.5 | 16.1 | 13.1 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 442.94 | 223.6 | 219 | 171.3 | |||||||||||||
income-statement-row.row.ebitda-caps | 1126.01 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 683.07 | 368.8 | 383.8 | 302.9 | |||||||||||||
income-statement-row.row.income-before-tax | 705.63 | 391.5 | 378.2 | 358.2 | |||||||||||||
income-statement-row.row.income-tax-expense | 134.77 | 75.8 | 72.9 | 73.5 | |||||||||||||
income-statement-row.row.net-income | 570.86 | 315.6 | 305.2 | 284.6 |
Често задавани въпроси
Какво е Perfect Medical Health Management Limited (1830.HK) общи активи?
Perfect Medical Health Management Limited (1830.HK) общите активи са 1296294000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 1439110000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.416.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.416.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.230.
Какъв е общият приход на предприятието?
Общият приход е 0.281.
Каква е Perfect Medical Health Management Limited (1830.HK) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 315638000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 240353000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 293788000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 632295000.000.